The IL-2/IL-2 receptor system: a target for rational immune intervention - PubMed (original) (raw)
Review
The IL-2/IL-2 receptor system: a target for rational immune intervention
T A Waldmann. Immunol Today. 1993 Jun.
Erratum in
- Immunol Today. 2008 Apr;29(4):149
Abstract
The expression of interleukin 2 (IL-2), induction of its multisubunit receptor and subsequent interplay of this ligand with its receptor are pivotal events in T-cell activation. Our present understanding of the normal IL-2/IL-2R system and of disorders in this network in disease opens the possibility for more specific immune intervention. Thomas Waldmann discusses the clinical application of IL-2, agents that inhibit IL-2 synthesis and action, and how the anti-IL-2 receptor-directed therapy provides a novel perspective for prevention of allograft rejection and for treatment of graft versus host disease, select autoimmune disorders and certain neoplastic diseases.
Similar articles
- The IL-2/IL-2 receptor system: a target for rational immune intervention.
Waldmann TA. Waldmann TA. Trends Pharmacol Sci. 1993 May;14(5):159-64. doi: 10.1016/0165-6147(93)90201-t. Trends Pharmacol Sci. 1993. PMID: 8212311 Review. - The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.
Waldmann TA, Goldman CK. Waldmann TA, et al. Am J Kidney Dis. 1989 Nov;14(5 Suppl 2):45-53. Am J Kidney Dis. 1989. PMID: 2683757 Review. - Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A.
Diamantstein T, Mouzaki A, Osawa H, Volk HD, Hahn HJ, Kirkman RL, Strom TB, Tilney NL, Kupiec-Weglinski JW. Diamantstein T, et al. Dev Biol Stand. 1988;69:177-84. Dev Biol Stand. 1988. PMID: 3066671 Review. No abstract available. - Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling.
Forward NA, Conrad DM, Power Coombs MR, Doucette CD, Furlong SJ, Lin TJ, Hoskin DW. Forward NA, et al. Biochem Biophys Res Commun. 2011 Apr 22;407(4):801-6. doi: 10.1016/j.bbrc.2011.03.103. Epub 2011 Apr 2. Biochem Biophys Res Commun. 2011. PMID: 21443863 - Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y, Qin Q, Chen J, Kuang X, Xia J, Xie B, Wang F, Liang H, Qi Z. Wang Y, et al. Transpl Immunol. 2009 Dec;22(1-2):5-11. doi: 10.1016/j.trim.2009.09.004. Epub 2009 Sep 18. Transpl Immunol. 2009. PMID: 19766187
Cited by
- DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response.
Mimran A, Mor F, Carmi P, Quintana FJ, Rotter V, Cohen IR. Mimran A, et al. J Clin Invest. 2004 Mar;113(6):924-32. doi: 10.1172/JCI17772. J Clin Invest. 2004. PMID: 15067325 Free PMC article. - Tregs in T cell vaccination: exploring the regulation of regulation.
Cohen IR, Quintana FJ, Mimran A. Cohen IR, et al. J Clin Invest. 2004 Nov;114(9):1227-32. doi: 10.1172/JCI23396. J Clin Invest. 2004. PMID: 15520852 Free PMC article. Review. - The Involvement of RCAS1 in Creating a Suppressive Tumor Microenvironment in Patients with Salivary Gland Adenocarcinoma.
Dutsch-Wicherek M, Lazar A, Tomaszewska R. Dutsch-Wicherek M, et al. Cancer Microenviron. 2010 Aug 20;4(1):13-21. doi: 10.1007/s12307-010-0051-6. Cancer Microenviron. 2010. PMID: 21505558 Free PMC article. - Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo.
Suzuki H, Zhou YW, Kato M, Mak TW, Nakashima I. Suzuki H, et al. J Exp Med. 1999 Dec 6;190(11):1561-72. doi: 10.1084/jem.190.11.1561. J Exp Med. 1999. PMID: 10587347 Free PMC article. - NMR characterization of interleukin-2 in complexes with the IL-2Ralpha receptor component, and with low molecular weight compounds that inhibit the IL-2/IL-Ralpha interaction.
Emerson SD, Palermo R, Liu CM, Tilley JW, Chen L, Danho W, Madison VS, Greeley DN, Ju G, Fry DC. Emerson SD, et al. Protein Sci. 2003 Apr;12(4):811-22. doi: 10.1110/ps.0232803. Protein Sci. 2003. PMID: 12649439 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources